What is the study about?
The goal of this study is to find out whether Darmiyan is an effective tool for diagnosing Alzheimer’s disease earlier. Darmiyan is a new software that can identify brain changes that may not be visible on traditional MRI brain scans. This project includes two studies to test how accurate and reliable Darmiyan is in predicting and detecting Alzheimer’s disease.
Eligibility – Who can participate?
Be able to speak English to complete neuropsychological testing
Have a caregiver who can come in and answer questions
Be 50 years of age or older
Either have no memory complaints, have mild cognitive impairment, or Alzheimer’s disease
Study 1 (a prospective study): A baseline visit with follow up at 4 to 9 months
Study 2 (a retrospective study): One visit following recruitment through chart review
TDRA study investigator
Dr. Morris Freedman